Hangzhou Changchuan Technology (300604) Q2 2026 earnings summary

Executive summary

• Revenue for H1 2026 reached ¥3.46 billion, up 59.72% year-over-year, with net profit attributable to shareholders at ¥963.67 million, up 125.67% year-over-year.

• Core business remains IC test equipment R&D, production, and sales, with continued expansion in high-end product lines and international markets.

• Major acquisitions include full control of PYXIS and ongoing integration of EXIS, enhancing product coverage and overseas presence.

Financial highlights

• Operating income: ¥3.46 billion, up 59.72% year-over-year.

• Net profit attributable to shareholders: ¥963.67 million, up 125.67% year-over-year.

• Gross margin: 55.5%; R&D investment: ¥761.08 million, 21.99% of revenue.

• Operating cash flow: ¥332.86 million, a significant turnaround from negative last year.

• Basic EPS: ¥1.52, up 123.53% year-over-year.

Outlook and guidance

• Focus on expanding high-end product lines (SoC testers, probe stations, AOI) and increasing international market share.

• R&D and product innovation remain strategic priorities, with continued investment planned.

• Guidance includes further integration of recent acquisitions and ongoing capacity expansion.